Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 31Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Multiple Myeloma 3Immunologic Deficiency Syndromes 2Thalassemia 1Neoplasms 1Myelodysplastic Syndromes 1Muscle Neoplasms 1Metabolic Diseases 1Melanoma 1Lymphoma 1Hemoglobinopathies 1Hematologic Neoplasms 1Fanconi Anemia 1Chronic Pain 1Breast Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

Surveys and Questionnaires 7Interviews as Topic 7Blood Specimen Collection 5Specimen Handling 4Exercise Test 4fludarabine 3Voriconazole 3Mental Status and Dementia Tests 3Bortezomib 3Standard of Care 2Observation 2Itraconazole 2Flow Cytometry 2Electronic Health Records 2Data Collection 2Antiviral Agents 2posaconazole 1liposomal amphotericin B 1isavuconazole 1glucarpidase 1fludarabine phosphate 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1Whole-Body Irradiation 1Watchful Waiting 1Vincristine 1Valganciclovir 1Transplantation 1Tomography, X-Ray Computed 1Tomography, Optical Coherence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hematologic Neoplasms × Melphalan × Clear all
NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡